"treatment of breast" trang 2 - tải miễn phí từ tailieuXANH
Triple negative breast cancer and platinumbased systemic treatment: A meta-analysis and systematic review

Triple negative breast cancer and platinumbased systemic treatment: A meta-analysis and systematic review
9    49    0
Cost-effectiveness of bevacizumab plus paclitaxel versus paclitaxel for the first-line treatment of HER2-negative metastatic breast cancer in specialist oncology centers in France

Cost-effectiveness of bevacizumab plus paclitaxel versus paclitaxel for the first-line treatment of HER2-negative metastatic breast cancer in specialist oncology centers in France
11    85    0
Adjuvant treatment recommendations for patients with ER-positive/HER2-negative early breast cancer by Swiss tumor boards using the 21-gene recurrence score (SAKK 26/10)

Adjuvant treatment recommendations for patients with ER-positive/HER2-negative early breast cancer by Swiss tumor boards using the 21-gene recurrence score (SAKK 26/10)
10    59    0
Serial enumeration of circulating tumor cells predicts treatment response and prognosis in metastatic breast cancer: A prospective study in 393 patients

Serial enumeration of circulating tumor cells predicts treatment response and prognosis in metastatic breast cancer: A prospective study in 393 patients
12    61    0
IL6 genotype, tumour ER-status, and treatment predicted disease-free survival in a prospective breast cancer cohort

IL6 genotype, tumour ER-status, and treatment predicted disease-free survival in a prospective breast cancer cohort
16    68    0
Surgical treatment of breast cancer in patients aged 80 years or older – how much is enough

Surgical treatment of breast cancer in patients aged 80 years or older – how much is enough
7    65    0
Influence of a patient information program on adherence and persistence with an aromatase inhibitor in breast cancer treatment - the COMPAS study

Influence of a patient information program on adherence and persistence with an aromatase inhibitor in breast cancer treatment - the COMPAS study
9    58    0
Population-based study of breast cancer in older women: Prognostic factors of relative survival and predictors of treatment

Population-based study of breast cancer in older women: Prognostic factors of relative survival and predictors of treatment
10    52    0
Precision treatment exploration of breast cancer based on heterogeneity analysis of lncRNAs at the single-cell level

Precision treatment exploration of breast cancer based on heterogeneity analysis of lncRNAs at the single-cell level
15    215    1
Impact of the line of treatment on progression-free survival in patients treated with T-DM1 for metastatic breast cancer

Impact of the line of treatment on progression-free survival in patients treated with T-DM1 for metastatic breast cancer
8    75    1
Assessment of the quality of life of breast cancer patients after one year of treatment

Assessment of the quality of life of breast cancer patients after one year of treatment
9    179    1
Unmet needs and related factors of Korean breast cancer survivors: A multicenter, cross-sectional study

Unmet needs and related factors of Korean breast cancer survivors: A multicenter, cross-sectional study
16    60    0
Successfully treatment by eribulin in visceral crisis: A case of lymphangitic carcinomatosis from metastatic breast cancer

Successfully treatment by eribulin in visceral crisis: A case of lymphangitic carcinomatosis from metastatic breast cancer
5    69    0
Phase II trial of eribulin mesylate as a firstor second-line treatment for locally advanced or metastatic breast cancer: A multicenter, single-arm trial

Phase II trial of eribulin mesylate as a firstor second-line treatment for locally advanced or metastatic breast cancer: A multicenter, single-arm trial
7    92    0
A randomized phase II study of paclitaxel alone versus paclitaxel plus sorafenib in second- and third-line treatment of patients with HER2-negative metastatic breast cancer (PASO)

A randomized phase II study of paclitaxel alone versus paclitaxel plus sorafenib in second- and third-line treatment of patients with HER2-negative metastatic breast cancer (PASO)
9    100    0
A mobile application of breast cancer e-support program versus routine Care in the treatment of Chinese women with breast cancer undergoing chemotherapy: Study protocol for a randomized controlled trial

A mobile application of breast cancer e-support program versus routine Care in the treatment of Chinese women with breast cancer undergoing chemotherapy: Study protocol for a randomized controlled trial
9    76    0
Prognosis and treatment of non-metastatic primary and secondary breast angiosarcoma: A comparative study

Prognosis and treatment of non-metastatic primary and secondary breast angiosarcoma: A comparative study
8    89    0
From symptom discovery to treatment - women's pathways to breast cancer care: A cross-sectional study

From symptom discovery to treatment - women's pathways to breast cancer care: A cross-sectional study
11    90    0
Redefining radiotherapy for early-stage breast cancer with single dose ablative treatment: A study protocol

Redefining radiotherapy for early-stage breast cancer with single dose ablative treatment: A study protocol
9    54    0
Angiogenic cytokines and their influence on circulating tumour cells in sera of patients with the primary diagnosis of breast cancer before treatment

Angiogenic cytokines and their influence on circulating tumour cells in sera of patients with the primary diagnosis of breast cancer before treatment
11    60    0
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.